ArticleBMJ neurology open2026
Longitudinal Orthostatic Tremor Study (LOTS): a multi-centre, prospective cohort protocol for characterising orthostatic tremor and orthostatic myoclonus.
Article in BMJ neurology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Orthostatic tremor (OT) is a rare movement disorder defined by high-frequency tremor predominantly in the standing position, often causing mobility limitation and reduced quality of life. Its natural history, disease burden and treatment response remain poorly understood due to limited longitudinal evidence. The Longitudinal Orthostatic Tremor Study (LOTS) aims to characterise clinical, demographic and therapeutic trajectories in OT and orthostatic myoclonus over 5 years. Methods and analysis: LOTS is a multicentre prospective cohort study expanding an initial retrospectively characterised cohort of 58 patients from a tertiary centre in India. Additional incident cases will be recruited across national and international sites over 2 years. Participants will undergo assessments at baseline, 6 months and annually for 5 years. Primary outcomes include the OT-10 scale and the novel OT Disease Burden Index. Secondary outcomes include electrophysiology (surface EMG), quality of life, OT Impact Profile and treatment response. Exploratory measures include neuroimaging, genetics, wearable-based metrics and gait analysis where feasible. Latent class analysis will identify subgroups with distinct trajectories, and mixed-effects models will assess longitudinal change and predictors of progression. Sensitivity analyses will account for differences between retrospective and prospective baselines. Anticipated limitations include attrition and variation in access to specialised electrophysiology. Trial registration number: This study has been registered with the Clinical Trials Registry-India (CTRI; Registration number: CTRI/2025/10/096248).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.